Enhanced investigation into NP toxicological profiles, coupled with innovations in targeted delivery systems to prolong circulatory residence time, could significantly improve treatment precision
Failure to eliminate dysfunctional mitochondria leads to the accumulation of mitochondrial ROS and the release of immunogenic mtDNA, both of which act as DAMPs that activate innate immune pathways, including the NLRP3 inflammasome and type I interferon (IFN-I) signaling
A peptide that survives one accidental overnight exposure at 70% of its original potency becomes 49% effective after a second identical exposure (0.70 0.70 = 0.49)
In February 2018, the FDA has approved a phase 1/2a study of bacteriophages specifically designed against adherent-invasive Escherichia coli (AIEC), to treat IBD
Consult a physician if pregnant/nursing, taking medication, or having a medical condition
Pain relief can last anywhere from several weeks to several months, depending on your specific condition, activity level, and the type of injection used